[Sensitivity of human melanoma xenografts to nitrosoalkylurea antineoplastic agents]. 1998

L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
Emanuel' Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia.

We studied the sensitivity of human melanoma (Bro strain) xenografts to drugs of the nitrosoalkylurea (NAU) class: nitrosomethylurea (NMM), karmustin (BCNU), nimustin (ACNU), nitrulin, and ADEKO. High antitumor activity of NAM was shown when the drugs were applied not only at the early, but also at the late stages of tumor progression (tumor mass 400 and 1200 mg, respectively). The therapeutic effect of the drugs was estimated with the use of criteria characterizing the kinetics of tumor regression, increased life span, and survival of treated animals. After early administration of the drugs (Day 4 after tumor transplantation), 67% and 50% of animals survive under the influence of nitrulin and ACNU, respectively, while the rate of tumor regression increased in the sequence nitrulin < karmustin < NMM < ACNU. After late administration (11 days after tumor transplantation), NMM was most effective at increasing survival (35% of survived animals by 35 days of observation), while the rate of tumor regression increased in the sequence ADEKO < NMM < karmustin < nitrulin < ACNU.

UI MeSH Term Description Entries
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D002330 Carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) BCNU,1,3-Bis(2-Chloroethyl)-1-Nitrosourea,BiCNU,FIVB,N,N'-Bis(2-Chloroethyl)-N-Nitrosourea,Nitrumon
D002956 Citrulline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
November 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
September 1994, Biulleten' eksperimental'noi biologii i meditsiny,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
January 1989, Carcinogenesis; a comprehensive survey,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
October 1984, Cancer research,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
January 1988, Progress in clinical and biological research,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
December 1980, International journal of cancer,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
August 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
October 1991, Biulleten' eksperimental'noi biologii i meditsiny,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
October 1992, The Tohoku journal of experimental medicine,
L A Ostrovskaia, and N M Ul'ianova, and M M Fomina, and V A Rykova, and A A Konradov, and E F Brin, and N V Gorbunova
May 2008, La Revue du praticien,
Copied contents to your clipboard!